Skip to main content
Contact us
Platform

A scaffold the body builds into.

MAP™ technology is based on a scaffold’s physical microenvironment and is compatible with any material chemistry, providing the foundation for Tempo’s minimally invasive, fully synthetic, precision-engineered tissue scaffolds.

What MAP™ stands forMAP™

Microporous Annealed Particle.

Hydrogel microparticles are delivered through a syringe. In the wound they link together into a stable scaffold with open pores between them.

Immersive macro view through open interparticle pores in an annealed hydrogel scaffold
Diagram highlighting open space between microgels
01 / Structure

Microporous

Interconnected spaces between the building blocks provide pathways for cellular infiltration.

Diagram of connected microgel building blocks with open central pore
02 / Assembly

Annealed

Individual microgels link together after placement to create a coherent porous scaffold.

Diagram of flowable particles moving through a narrow channel
03 / Delivery

Particle

Flowable microgel building blocks can conform to irregular spaces prior to assembly.

How the MAP™ biosurgery product works

From wound to new tissue.

A sequential view of the MAP™ material concept, from syringe delivery to tissue infiltration. View Tempo’s original technology overview ↗

01
Conceptual skin cutaway showing an irregular wound volume

Complex wound

An irregular wound volume requires a material that can adapt to the defect.

02
Conceptual applicator delivery of hydrogel microparticles into a skin defect

Flow into wound

Flowable MAP™ building blocks are delivered directly into the wound bed.

03
Conceptual linked granular scaffold filling a skin defect with open interparticle pores

Anneal scaffold

The microparticles connect and create a stable scaffold while maintaining open porosity.

04
Conceptual host tissue infiltration among resorbing hydrogel particles

Tissue regrowth

Host cells can infiltrate the pores as tissue regenerates and the scaffold resorbs.

Hydrogel microparticlesInterparticle poresHost tissue and cells
Properties

Designed to be tuned.

Tempo’s lead asset, TT101, is a stand-alone material with no cells or biological factors. The wider MAP™ platform can be adjusted and combined.

Fully synthetic

No cells or biological factors in TT101.

Bioresorbable

Gradually replaced by the patient’s own tissue.

Tunable

Stiffness and durability can be adjusted, from weeks to years.

Combinable

Can be paired with controlled release of small molecules and with stem cells.

Origin

From the lab that started annealed granular scaffolds.

MAP™ was first described by Tempo’s founders in Nature Materials in 2015, a paper cited more than 1,500 times. More than 200 papers have since been published on the technology, and Tempo holds 23 issued patents across 7 patent families.

Platform potential · published research
Published studies Wound healingNature Materials, 2015↗ VaccinesPubMed↗ Myocardial infarctionAdvanced Functional Materials↗ StrokeAdvanced Materials↗
Other applications
Abdominal wallSoft tissueCell engraftmentAllogeneic cellsDrug deliveryCombinationRegenerative / dermal fillerAesthetics